For instance, habitual medications for lifestyle-related diseases, such as angiotensin-converting enzyme inhibitor, ARB, metformin, statin, aspirin, and nonsteroidal anti-inflammatory drugs, are negative risk factors for CRC, whereas insulin is a positive risk factor [18–24]. This evidence concerns the gene ACE and colorectal carcinoma.